Asia Pacific Genomics Market was worth USD 3.28 billion in 2018 and estimated to be growing at a CAGR of 10.5%, to reach USD 5.41 billion by 2023. Within the field of molecular biology, genomics is the study of genomes, the complete set of genetic material within an organism. Genomics involves the sequencing and analysis of genomes. Genomics is also concerned with the structure, function, comparison, and evolution of genomes.
The Asia Pacific genomics market is expected to grow at the highest CAGR during the forecast period due to increasing awareness and adoption of various genomics techniques in emerging countries such as India and China for detection, prognosis and treating various genetic disorders such as cancer, diabetes, and others. In addition to this, improving healthcare infrastructure, high unmet medical needs, rising patient disposable incomes and growing health care expenditures are also the drivers for the growth of this market. However, the expensive genomic instruments pose a major problem to the growth of the market.
The report segments the market based on product, technology, process, application and end user. The various product segments of the genomics market include instruments/systems, consumables, and services. The consumables segment is expected to account for the largest share of the genomics market. This is attributed to factors such as repeated usage of consumables for the genomic experiments, increasing research programs by academic institutes and non-profit organizations. The market by technology is segmented into Sequencing, Microarray technology, PCR, Nucleic acid extraction and other technologies. Based on the various application areas of genomics, the report segments the market into diagnostics, drug discovery & development, personalized medicine, and agriculture & animal research, among others. The market by process is segmented into the library preparation, sequencing & imaging, and data analysis. Based on the end users the genomics market is segmented into research centres, academic institutes, & government institutes; hospitals & clinics; and pharmaceutical & biotechnology companies, among others. The research centres, academic institutes, and government institutes segment accounted for the largest share of the market, by end user. This largest share is attributed to the increasing research initiatives and projects in the area of genomics worldwide. On the basis of geography, the market is analysed under various regions namely India, China, Japan, Australia and South Korea. The Asian market, especially India and China, is expected to witness a boost in demand for genomics market during the forecast period registering the highest CAGR.
Some of the key players in this market include Affymetrix, Inc., Agilent Technologies, BGI, Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., Qiagen, Roche Diagnostics, Life Technologies, Cepheid.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Instruments/systems
5.1.3 Consumables
5.1.4 Services
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Process
5.2.1 Introduction
5.2.2 Library prepration
5.2.3 Sequencing and imaging
5.2.4 Data Analysis
5.2.5 Y-o-Y Growth Analysis, By Process
5.2.6 Market Attractiveness Analysis, By Process
5.2.7 Market Share Analysis, By Process
5.3 Technology
5.3.1 Introduction
5.3.2 Sequencing
5.3.3 Microarray technology
5.3.4 PCR
5.3.5 Nucleic Acid Extraction and Purification
5.3.6 Other technologies
5.3.7 Y-o-Y Growth Analysis, By Technology
5.3.8 Market Attractiveness Analysis, By Technology
5.3.9 Market Share Analysis, By Technology
5.4 Application
5.4.1 Introduction
5.4.2 Diagnostics
5.4.2.1 Cancer diagnostics
5.4.2.2 Monogenic diagnostics
5.4.2.3 Other diagnostic applications
5.4.3 Drug discovery and development
5.4.4 Personalized medicine
5.4.5 Agriculture and animal research
5.4.6 Other applications
5.4.7 Y-o-Y Growth Analysis, By Application
5.4.8 Market Attractiveness Analysis, By Application
5.4.9 Market Share Analysis, By Application
5.5 End user
5.5.1 Introduction
5.5.2 Research Centers, Academic Institutes, and Government Institutes
5.5.3 Hospitals and clinics
5.5.4 Pharmaceutical and biotechnological companies
5.5.5 Other end users
5.4.6 Y-o-Y Growth Analysis, By End user
5.4.7 Market Attractiveness Analysis, By End user
5.4.8 Market Share Analysis, By End user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Process
6.1.3.4 By Technology
6.1.3.5 By Application
6.1.3.6 By end user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Process
6.1.4.4 By Technology
6.1.4.5 By Application
6.1.4.6 By end user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Process
6.1.5.4 By Technology
6.1.5.5 By End user
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Affymetrix Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Agilent Technologies
8.3 BGI
8.4 Bio-Rad Laboratories Inc.
8.5 GE Healthcare
8.6 Illumnia Inc.
8.7 Qiagen
8.8 Roche Diagnostics
8.9 Life technologies
8.10 Cepheid
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
